These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36619047)

  • 1. A nomological network for misophonia in two German samples using the S-Five model for misophonia.
    Remmert N; Jebens A; Gruzman R; Gregory J; Vitoratou S
    Front Psychol; 2022; 13():902807. PubMed ID: 36619047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond sound irritation: cross-cultural evidence on the robustness of the five aspects of misophonic experience measured by the S-Five in a Polish sample.
    Uglik-Marucha N; Siepsiak M; Zielińska J; Dragan WŁ; Gregory J; Vitoratou S
    Front Psychol; 2024; 15():1372870. PubMed ID: 38962216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of Cross-Cultural Consistency of the S-Five Model for Misophonia: Psychometric Conclusions Emerging From the Mandarin Version.
    Vitoratou S; Wang J; Hayes C; Wang Q; Stefanatou P; Gregory J
    Front Psychol; 2022; 13():879881. PubMed ID: 35959032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emotion Processes Predicting Outbursts and Functional Impact in Misophonia.
    Wang Q; Vitoratou S; Uglik-Marucha N; Gregory J
    Front Psychol; 2022; 13():903142. PubMed ID: 35859827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Evaluation and Misophonic Experience in a Portuguese-Speaking Sample.
    Hayes C; Gregory J; Aziz R; Cerejeira J; Cruz M; Simões JA; Vitoratou S
    Behav Sci (Basel); 2024 Jan; 14(2):. PubMed ID: 38392460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misophonia in the UK: Prevalence and norms from the S-Five in a UK representative sample.
    Vitoratou S; Hayes C; Uglik-Marucha N; Pearson O; Graham T; Gregory J
    PLoS One; 2023; 18(3):e0282777. PubMed ID: 36947525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Berlin Misophonia Questionnaire Revised (BMQ-R): Development and validation of a symptom-oriented diagnostical instrument for the measurement of misophonia.
    Remmert N; Schmidt KMB; Mussel P; Hagel ML; Eid M
    PLoS One; 2022; 17(6):e0269428. PubMed ID: 35727794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric validation of a brief self-report measure of misophonia symptoms and functional impairment: The duke-vanderbilt misophonia screening questionnaire.
    Williams ZJ; Cascio CJ; Woynaroski TG
    Front Psychol; 2022; 13():897901. PubMed ID: 35936331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal investigation of quality of life and negative emotions in misophonia.
    Dibb B; Golding SE
    Front Neurosci; 2022; 16():900474. PubMed ID: 35937869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central role of symptom severity and associated characteristics for functional impairment in misophonia.
    Möllmann A; Heinrichs N; Illies L; Potthast N; Kley H
    Front Psychiatry; 2023; 14():1112472. PubMed ID: 37056403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of Affective Responses in Misophonia Depends on Trigger Identification.
    Savard MA; Sares AG; Coffey EBJ; Deroche MLD
    Front Neurosci; 2022; 16():879583. PubMed ID: 35692416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining emotional functioning in misophonia: The role of affective instability and difficulties with emotion regulation.
    Guetta RE; Cassiello-Robbins C; Trumbull J; Anand D; Rosenthal MZ
    PLoS One; 2022; 17(2):e0263230. PubMed ID: 35148347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study of a rage-related misophonia symptom and the genetic link with audiological traits, psychiatric disorders, and personality.
    Smit DJA; Bakker M; Abdellaoui A; Hoetink AE; Vulink N; Denys D
    Front Neurosci; 2022; 16():971752. PubMed ID: 36760791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and validation of the Misophonia response scale.
    Dibb B; Golding SE; Dozier TH
    J Psychosom Res; 2021 Oct; 149():110587. PubMed ID: 34390941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misophonia: A new mental disorder?
    Taylor S
    Med Hypotheses; 2017 Jun; 103():109-117. PubMed ID: 28571795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory affective processing, musicality, and the development of misophonic reactions.
    Mednicoff SD; Barashy S; Gonzales D; Benning SD; Snyder JS; Hannon EE
    Front Neurosci; 2022; 16():924806. PubMed ID: 36213735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The New York Misophonia Scale (NYMS): A New Instrument to Identify Misophonia in the General Population.
    Barahmand U; Stalias-Mantzikos ME; Xiang Y; Rotlevi E
    J Psychiatr Pract; 2023 Jul; 29(4):269-281. PubMed ID: 37449825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Brain Basis for Misophonia.
    Kumar S; Tansley-Hancock O; Sedley W; Winston JS; Callaghan MF; Allen M; Cope TE; Gander PE; Bamiou DE; Griffiths TD
    Curr Biol; 2017 Feb; 27(4):527-533. PubMed ID: 28162895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misophonia in Singaporean Psychiatric Patients: A Cross-Sectional Study.
    Quek TC; Ho CS; Choo CC; Nguyen LH; Tran BX; Ho RC
    Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 29973546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Initial Validation of the Duke Misophonia Questionnaire.
    Rosenthal MZ; Anand D; Cassiello-Robbins C; Williams ZJ; Guetta RE; Trumbull J; Kelley LD
    Front Psychol; 2021; 12():709928. PubMed ID: 34659024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.